We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
The current CNSL market cap is 8.8M. The company's latest EPS is GBP -0.0010 and P/E is -37.00.
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Revenue | 9.82M | 8.74M | 12.33M | 8.19M | 9.77M |
| Operating Income | -9.1M | -3.46M | -8.61M | -4.09M | -569k |
| Net Income | -6.83M | -2.1M | -11.33M | -3.86M | -231k |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Total Assets | 18.84M | 29.55M | 17.84M | 14.41M | 13.89M |
| Total Liabilities | 5.23M | 6.16M | 6.02M | 4.45M | 4.21M |
| Total Equity | 13.61M | 23.38M | 11.82M | 9.95M | 9.68M |
| Year End March 30 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| GBP (£) | GBP (£) | GBP (£) | GBP (£) | GBP (£) | |
| Operating | 548k | -2.42M | -3.23M | -3.15M | 607k |
| Investing | -2.15M | -2.83M | -493k | 5.18M | -2.51M |
| Financing | 1.64M | 11.07M | -502k | 1.49M | -265k |
| Market Cap | 8.8M |
| Price to Earnings Ratio | -37.00 |
| Price to Sales Ratio | 0.9 |
| Price to Cash Ratio | 2.98 |
| Price to Book Ratio | 0.91 |
| Dividend Yield | - |
| Shares Outstanding | 237.95M |
| Average Volume (1 week) | 183.4k |
| Average Volume (1 Month) | 225.66k |
| 52 Week Change | 92.21% |
| 52 Week High | 4.45 |
| 52 Week Low | 1.725 |
| Spread (Intraday) | 0.4 (10.26%) |
| Company Name | Cambridge Nutritional Sciences Plc |
| Address |
omega house scotland FK12 5DQ |
| Website | https://www.omegadiagnostics.com |
| Industry | diversified industrial holding (D11) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
